Literature DB >> 29408321

Status of acute systemic toxicity testing requirements and data uses by U.S. regulatory agencies.

Judy Strickland1, Amy J Clippinger2, Jeffrey Brown3, David Allen4, Abigail Jacobs5, Joanna Matheson6, Anna Lowit7, Emily N Reinke8, Mark S Johnson9, Michael J Quinn10, David Mattie11, Suzanne C Fitzpatrick12, Surender Ahir13, Nicole Kleinstreuer14, Warren Casey15.   

Abstract

Acute systemic toxicity data are used by a number of U.S. federal agencies, most commonly for hazard classification and labeling and/or risk assessment for acute chemical exposures. To identify opportunities for the implementation of non-animal approaches to produce these data, the regulatory needs and uses for acute systemic toxicity information must first be clarified. Thus, we reviewed acute systemic toxicity testing requirements for six U.S. agencies (Consumer Product Safety Commission, Department of Defense, Department of Transportation, Environmental Protection Agency, Food and Drug Administration, Occupational Safety and Health Administration) and noted whether there is flexibility in satisfying data needs with methods that replace or reduce animal use. Understanding the current regulatory use and acceptance of non-animal data is a necessary starting point for future method development, optimization, and validation efforts. The current review will inform the development of a national strategy and roadmap for implementing non-animal approaches to assess potential hazards associated with acute exposures to industrial chemicals and medical products. The Acute Toxicity Workgroup of the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM), U.S. agencies, non-governmental organizations, and other stakeholders will work to execute this strategy.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute systemic toxicity; Alternative approaches; In silico; In vitro; LC(50); LD(50); Non-animal methods; Regulatory requirements

Mesh:

Year:  2018        PMID: 29408321      PMCID: PMC5878133          DOI: 10.1016/j.yrtph.2018.01.022

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  11 in total

1.  Reconstituting organ-level lung functions on a chip.

Authors:  Dongeun Huh; Benjamin D Matthews; Akiko Mammoto; Martín Montoya-Zavala; Hong Yuan Hsin; Donald E Ingber
Journal:  Science       Date:  2010-06-25       Impact factor: 47.728

Review 2.  The third dimension bridges the gap between cell culture and live tissue.

Authors:  Francesco Pampaloni; Emmanuel G Reynaud; Ernst H K Stelzer
Journal:  Nat Rev Mol Cell Biol       Date:  2007-10       Impact factor: 94.444

3.  A new path forward: the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and National Toxicology Program's Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM).

Authors:  Warren Casey; Abigail Jacobs; Elizabeth Maull; Joanna Matheson; Carol Clarke; Anna Lowit
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-03       Impact factor: 1.232

Review 4.  Alternative approaches for identifying acute systemic toxicity: Moving from research to regulatory testing.

Authors:  Jon Hamm; Kristie Sullivan; Amy J Clippinger; Judy Strickland; Shannon Bell; Barun Bhhatarai; Bas Blaauboer; Warren Casey; David Dorman; Anna Forsby; Natàlia Garcia-Reyero; Sean Gehen; Rabea Graepel; Jon Hotchkiss; Anna Lowit; Joanna Matheson; Elissa Reaves; Louis Scarano; Catherine Sprankle; Jay Tunkel; Dan Wilson; Menghang Xia; Hao Zhu; David Allen
Journal:  Toxicol In Vitro       Date:  2017-01-06       Impact factor: 3.500

5.  Bridging the gap between regulatory acceptance and industry use of non-animal methods.

Authors:  Amy J Clippinger; Erin Hill; Rodger Curren; Patricia Bishop
Journal:  ALTEX       Date:  2016-06-02       Impact factor: 6.043

6.  Co-culture of Living Microbiome with Microengineered Human Intestinal Villi in a Gut-on-a-Chip Microfluidic Device.

Authors:  Hyun Jung Kim; Jaewon Lee; Jin-Ha Choi; Anthony Bahinski; Donald E Ingber
Journal:  J Vis Exp       Date:  2016-08-30       Impact factor: 1.355

7.  Chip-based human liver-intestine and liver-skin co-cultures--A first step toward systemic repeated dose substance testing in vitro.

Authors:  Ilka Maschmeyer; Tobias Hasenberg; Annika Jaenicke; Marcus Lindner; Alexandra Katharina Lorenz; Julie Zech; Leif-Alexander Garbe; Frank Sonntag; Patrick Hayden; Seyoum Ayehunie; Roland Lauster; Uwe Marx; Eva-Maria Materne
Journal:  Eur J Pharm Biopharm       Date:  2015-04-06       Impact factor: 5.571

8.  Alternative approaches for acute inhalation toxicity testing to address global regulatory and non-regulatory data requirements: An international workshop report.

Authors:  Amy J Clippinger; David Allen; Annie M Jarabek; Marco Corvaro; Marianna Gaça; Sean Gehen; Jon A Hotchkiss; Grace Patlewicz; Jodie Melbourne; Paul Hinderliter; Miyoung Yoon; Dongeun Huh; Anna Lowit; Barbara Buckley; Michael Bartels; Kelly BéruBé; Daniel M Wilson; Ian Indans; Mathieu Vinken
Journal:  Toxicol In Vitro       Date:  2017-12-22       Impact factor: 3.500

9.  A European pharmaceutical company initiative challenging the regulatory requirement for acute toxicity studies in pharmaceutical drug development.

Authors:  Sally Robinson; Jean-Luc Delongeas; Elizabeth Donald; David Dreher; Matthias Festag; Sophie Kervyn; Ann Lampo; Kamil Nahas; Vicente Nogues; Deborah Ockert; Kirsty Quinn; Sally Old; Nigel Pickersgill; Kev Somers; Claudia Stark; Peter Stei; Lynne Waterson; Kathryn Chapman
Journal:  Regul Toxicol Pharmacol       Date:  2007-12-05       Impact factor: 3.271

Review 10.  Three-dimensionally engineered biomimetic tissue models for in vitro drug evaluation: delivery, efficacy and toxicity.

Authors:  Yvonne Peck; Dong-An Wang
Journal:  Expert Opin Drug Deliv       Date:  2013-01-06       Impact factor: 6.648

View more
  14 in total

1.  Transitioning the Generalised Read-Across approach (GenRA) to quantitative predictions: A case study using acute oral toxicity data.

Authors:  George Helman; Imran Shah; Grace Patlewicz
Journal:  Comput Toxicol       Date:  2019-11-01

Review 2.  Unintended effects of drug carriers: Big issues of small particles.

Authors:  Hamideh Parhiz; Makan Khoshnejad; Jacob W Myerson; Elizabeth Hood; Priyal N Patel; Jacob S Brenner; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2018-07-03       Impact factor: 15.470

3.  CATMoS: Collaborative Acute Toxicity Modeling Suite.

Authors:  Kamel Mansouri; Agnes L Karmaus; Jeremy Fitzpatrick; Grace Patlewicz; Prachi Pradeep; Domenico Alberga; Nathalie Alepee; Timothy E H Allen; Dave Allen; Vinicius M Alves; Carolina H Andrade; Tyler R Auernhammer; Davide Ballabio; Shannon Bell; Emilio Benfenati; Sudin Bhattacharya; Joyce V Bastos; Stephen Boyd; J B Brown; Stephen J Capuzzi; Yaroslav Chushak; Heather Ciallella; Alex M Clark; Viviana Consonni; Pankaj R Daga; Sean Ekins; Sherif Farag; Maxim Fedorov; Denis Fourches; Domenico Gadaleta; Feng Gao; Jeffery M Gearhart; Garett Goh; Jonathan M Goodman; Francesca Grisoni; Christopher M Grulke; Thomas Hartung; Matthew Hirn; Pavel Karpov; Alexandru Korotcov; Giovanna J Lavado; Michael Lawless; Xinhao Li; Thomas Luechtefeld; Filippo Lunghini; Giuseppe F Mangiatordi; Gilles Marcou; Dan Marsh; Todd Martin; Andrea Mauri; Eugene N Muratov; Glenn J Myatt; Dac-Trung Nguyen; Orazio Nicolotti; Reine Note; Paritosh Pande; Amanda K Parks; Tyler Peryea; Ahsan H Polash; Robert Rallo; Alessandra Roncaglioni; Craig Rowlands; Patricia Ruiz; Daniel P Russo; Ahmed Sayed; Risa Sayre; Timothy Sheils; Charles Siegel; Arthur C Silva; Anton Simeonov; Sergey Sosnin; Noel Southall; Judy Strickland; Yun Tang; Brian Teppen; Igor V Tetko; Dennis Thomas; Valery Tkachenko; Roberto Todeschini; Cosimo Toma; Ignacio Tripodi; Daniela Trisciuzzi; Alexander Tropsha; Alexandre Varnek; Kristijan Vukovic; Zhongyu Wang; Liguo Wang; Katrina M Waters; Andrew J Wedlake; Sanjeeva J Wijeyesakere; Dan Wilson; Zijun Xiao; Hongbin Yang; Gergely Zahoranszky-Kohalmi; Alexey V Zakharov; Fagen F Zhang; Zhen Zhang; Tongan Zhao; Hao Zhu; Kimberley M Zorn; Warren Casey; Nicole C Kleinstreuer
Journal:  Environ Health Perspect       Date:  2021-04-30       Impact factor: 9.031

4.  Predictive Models for Acute Oral Systemic Toxicity: A Workshop to Bridge the Gap from Research to Regulation.

Authors:  Nicole C Kleinstreuer; Agnes Karmaus; Kamel Mansouri; David G Allen; Jeremy M Fitzpatrick; Grace Patlewicz
Journal:  Comput Toxicol       Date:  2018-11

5.  First Food and Drug Administration Cleared Thin-Film Electrode for Intracranial Stimulation, Recording, and Monitoring of Brain Activity-Part 1: Biocompatibility Testing.

Authors:  Aura Kullmann; Debra Kridner; Steve Mertens; Mark Christianson; Dave Rosa; Camilo A Diaz-Botia
Journal:  Front Neurosci       Date:  2022-04-29       Impact factor: 5.152

6.  A cross-industry collaboration to assess if acute oral toxicity (Q)SAR models are fit-for-purpose for GHS classification and labelling.

Authors:  Joel Bercu; Melisa J Masuda-Herrera; Alejandra Trejo-Martin; Catrin Hasselgren; Jean Lord; Jessica Graham; Matthew Schmitz; Lawrence Milchak; Colin Owens; Surya Hari Lal; Richard Marchese Robinson; Sarah Whalley; Phillip Bellion; Anna Vuorinen; Kamila Gromek; William A Hawkins; Iris van de Gevel; Kathleen Vriens; Raymond Kemper; Russell Naven; Pierre Ferrer; Glenn J Myatt
Journal:  Regul Toxicol Pharmacol       Date:  2020-12-17       Impact factor: 3.271

7.  A predictive in vitro risk assessment platform for pro-arrhythmic toxicity using human 3D cardiac microtissues.

Authors:  Celinda M Kofron; Tae Yun Kim; Bum-Rak Choi; Kareen L K Coulombe; Fabiola Munarin; Arvin H Soepriatna; Rajeev J Kant; Ulrike Mende
Journal:  Sci Rep       Date:  2021-05-13       Impact factor: 4.379

8.  Evaluation of Variability Across Rat Acute Oral Systemic Toxicity Studies.

Authors:  Agnes L Karmaus; Kamel Mansouri; Kimberly T To; Bevin Blake; Jeremy Fitzpatrick; Judy Strickland; Grace Patlewicz; David Allen; Warren Casey; Nicole Kleinstreuer
Journal:  Toxicol Sci       Date:  2022-06-28       Impact factor: 4.109

9.  Harnessing the power of novel animal-free test methods for the development of COVID-19 drugs and vaccines.

Authors:  Francois Busquet; Thomas Hartung; Giorgia Pallocca; Costanza Rovida; Marcel Leist
Journal:  Arch Toxicol       Date:  2020-05-23       Impact factor: 5.153

10.  Nonanimal Models for Acute Toxicity Evaluations: Applying Data-Driven Profiling and Read-Across.

Authors:  Daniel P Russo; Judy Strickland; Agnes L Karmaus; Wenyi Wang; Sunil Shende; Thomas Hartung; Lauren M Aleksunes; Hao Zhu
Journal:  Environ Health Perspect       Date:  2019-04       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.